Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Apr 08, 2019 1:45 PM - Apr 11, 2019 11:00 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Affairs: The IND, NDA, and Post-Marketing

Session 21: Regulatory Compliance and FDA Inspections: What To Expect After Submitting the NDA

Session Chair(s)

Elliott  Berger, PhD, MS

Elliott Berger, PhD, MS

President

ETB Regualtory Consulting, United States

  • GLP Inspections
  • GCP Inspections
  • Inspection Outcomes: Additional Considerations in GCP Inspections
  • GMP Inspections
  • Inspection Outcomes (GLPs, GCPs, GMPs)
  • FDA Enforcement Actions
  • Application Integrity Policy (AIP)
  • Inspection Video (optional)

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.